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In mice injected with superantigens, T cells specific 
for that antigen proliferate and then die. It has been 
suggested that the target cells die because they en- 
counter superantigen on the surfaces of nonprofes- 
sional presenting cells, such as B cells, which cannot 
deliver costimulatory signals to T cells. A number of 
reagents that induce costimulatory molecules on B 
cells were tested. Lipopolysaccharide very effectively 
prevented T cell death driven by superantigen. Per- 
haps surprisingly, the action of lipopolysaccharide 
was not mediated through the expected costimulatory 
molecule, 87. Rather, the effects of lipopolysaccha- 
ride involved the production of inflammatory cyto- 
kines, in particular TNFa. The rescued cells survived in 
vitro culture and were resistant to Fas-induced killing. 
These data demonstrate that LPS can block antigen- 
induced T cell death perhaps by interfering with Fas 
signaling. 
introduction 
Staphylococcal enterotoxin A (SEA) is a superantigen that 
binds to class II major histocompatibility complex (MHC) 
proteins and engages T cells that bear VP3 as a part of 
their receptors for antigen (Marrack and Kappler, 1990; 
Callahan et al, 1990; Herman et al., 1991; Kawabe and 
Ochi, 1991; MacDonald et al., 1991). Thus, as shown pre- 
viously, injection of SEA into BlO.BR mice drives the 
expansion of both CD4+ and CD8+ T cells bearing Vp3. 
Ironically, the majority of the CD4+ Vfi3+ T cells die within 
aweekof asingle injection of SEA, such that their numbers 
fall significantly below those in normal uninjected mice 
(McCormack et al., 1993, 1994). 
This phenomenon of peripheral deletion is not well un- 
derstood, although it probably involves induction of Fas 
protein on the surface of the responding lymphocytes and 
death of these cells following engagement of Fas by Fas 
ligand (Watanabe-Fukunaga et al., 1992; Singer and Ab- 
bas, 1994). Moreover, nothing is known about what might 
overcome the phenomenon and allow a long-lived T cell 
response. Some clues might be provided by experiments 
on T cell anergy, defined as the failure of T ceils to divide 
and produce interleukin-2 (IL-2) in response to specific 
antigen (Jenkins et al., 1987a, 1987b; Jenkins and 
Schwartz, 1987). It is known that some T cell clones be- 
come anergic when stimulated through their TCRs (signal 
1) without appropriate costimulation through interactions 
between proteins such as T cell surface CD28 with pres- 
enting cell 87-l and 87-2 (signal 2) (Jenkins and Schwartz, 
1987; Jenkinset al., 1991; Hardinget al., 1992). Superanti- 
gens do not have to be processed before they can bind 
class II MHC proteins and engage TCRs (Fleisher and 
Schrezenmeier, 1988). Therefore, unlike conventional 
peptide antigens, superantigens do not require the ser- 
vices of professional antigen-presenting cells (APCs) to 
engage T cells. Because of this, superantigens, unlike 
peptide antigens, are probably presented to T cells in vivo 
on thesurfacesofthemajorsourceofclassllin theanimal, 
resting B cells. These cells do not bear appreciable 
amounts of 87 (Linsley et al., 1991; Razi-Wolf et al., 1992) 
and thus can deliver only signal 1 to T cells. T cell death 
or inactivation in animals, driven by superantigens, may 
therefore be owing to delivery of signal 1 to the T cells in 
the absence of signal 2, just as T cell anergy is caused 
by similar circumstances in the in vitro models discussed 
above. 
The experiments described in this paper were designed 
to test this idea. Preliminary experiments with anti- 
immunoglobulin D (anti-IgD), which increases levels of 87 
on B cells (Morris et al., 1994), or anti-CD28, which mimics 
87 engagement (Jenkins et al., 1991; Townsend and Alli- 
son, 1993), suggested that the hypothesis was not correct. 
To follow up an alternate idea, mice were challenged with 
SEA in the presence of bacterial lipopolysaccharide (LPS), 
a material which has previously been shown to interfere 
with T cell tolerance (Chiller and Weigle, 1973; Parks et 
al., 1981). Exposure to LPS did indeed block deletion of 
reactive T cells by SEA. LPS induces B7 expression by 
B cells (Razi-Wolf et al., 1992); however, surprisingly, T 
cell rescue by LPS was not inhibited by administration 
to the animals of large amounts of a reagent, CTLACIg 
(Linsley et al., 1991, 1992), known to interfere with the 
binding of T cell CD28 by 87-l and 87-2 (Azuma et al., 
1993; Freeman et al., 1993a, 1993b; Hathcock et al., 
1993). This was not because the CTLACIg was ineffective 
in vivo since, in control experiments, CTLA4-lg strongly 
inhibited T cell priming with a conventional peptide anti- 
gen, pigeon cytochrome c 88-104 (PCC 88-104). Thus, 
LPS did not prevent SEA-induced T cell death by raising 
the levels of 87 on B cells. 
To test another hypothesis, that LPS might induce sur- 
vival signals in the form of inflammatory cytokines, we 
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examined the effects of neutralizing antibodies to tumor 
necrosis factor-a (TNFa) and interferon-y (IFNy) on the 
phenomenon. Anti-TNFa and, to a lesser extent anti-IFNy, 
significantly reduced the rescuing effect of LPS. 
Finally, in attempts to find out how LPS, TNFa, or both 
interfered with T cell death, we demonstrated that almost 
all of the rescued T cells bore Fas on their surfaces. In 
spite of this, these cells could not be killed by engagement 
of Fas. Thus, LPS appeared to rescue Tcellsfrom antigen- 
induced death by interfering with the ability of Fas to in- 
duce death in cells bearing it. These data suggest that T 
cell survival after exposure to superantigen, and perhaps 
also conventional foreign or auto antigen, in vivo may 
sometimes depend upon bystander nonspecific inflamma- 
tory mediators such as TNFa induced by the mechanisms 
of innate immunity in response to infection by procaryotic 
organisms. 
Results 
T Cells Cannot Se Rescued from 
Superantigen-Mediated Death by Reagents 
That Deliver Signal 2 
V83-bearing T cells in mice given SEA die (Webb et al., 
1990; Kawabe and Ochi, 1991; MacDonald et al., 1991; 
McCormack, 1993). It is possible that these cells die be- 
cause they receive one signal, delivered by engagement 
of their a8 TCRs, in the absence of a second (Rellahan et 
al., 1990). Current ideas suggest that thissecond essential 
signal may be delivered by engagement of CD28 on the 
surface of the T cells by B7-like proteins on the surface 
of APCs (Jenkins et al., 1991; Harding et al., 1992). To 
test this idea, mice were given SEA and one of various 
reagents thought to induce 87 on presenting cells or 
known to substitute for 87 in CD28 engagement. These 
reagents included anti-IgD (Morris et al., 1994) and anti- 
CD28 (Townsend and Allison, 1993). Although the anti-IgD 
did raise class II and 87 levels on B cells in recipient mice 
(data not shown), and although the anti-CD28 was used 
at doses known to be effective in vivo, neither of these 
reagents had any effect on Tcell death after administration 
of staphylococcal enterotoxin B (SEB) or SEA (data not 
shown). These experiments led us to speculate that lack 
of CD28 engagement might not be the only reason why 
superantigens kill mature T cells in vivo and caused us 
to test the effects of other procedures. 
LPS Rescues Mature T Cells from 
Superantigen-Mediated Death 
Many years ago, Chiller and Weigle (1973) showed that 
LPS could inhibit induction of tolerance by soluble protein 
antigens. With this in mind, LPS was tested for its ability 
to prevent SEA-mediated death of V83+ T cells. Mice were 
injected with LPS at various times before or after adminis- 
tration of SEA and percentages of V83-bearing T cells 
were monitored 8 days after the SEA injection. 
As shown in Figure 1, LPS given at the same time as, 
or 24 hr after, SEA injection did increase the percentage 
of CD4 and CD8 Vj33+ T cells found in spleen 8 days later 
(p < 0.05) by comparison with mice given SEA alone or 
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Figure 1. Bacterial LPS Mediates the Rescue of TCR Vj33+ T Cells 
from SEA-Induced Death 
Mice were injected with 0.04 pg SEA intraperitoneally at 0 hr with or 
without an intravenous injection of 60 pg of LPS at various times rela- 
tive to the SEA injection. T cells were purified 6 days after the SEA 
injection by passage over nylon wool columns and analyzed for CD4- 
V63, CD6J.93, and CD4914 expression. The data shown are the 
averages f SD of three separate experiments with one mouse in 
each group. 
even by comparison with normal mice. Similar results were 
observed inlymph nodes (LN) (data not shown). Increases 
in the percentage of V83+ T cells led to compensatory 
decreases in the percentages of T cells bearing TCRs that 
do not react with SEA, represented here by the V814+ 
population (Figure 1). The increases in the percentages 
of Vj33+ cells induced by SEA plus LPS were reflected 
in increases in their actual numbers, even though LPS 
actually caused a decrease in the total numbers of T cells 
found in spleen and LN (Table 1). 
Injection of SEA caused V83’ T cells to divide before 
they die (Figure 2; McCormack et al., 1993). LPS injection 
into SEA-treated mice delayed the initial increase in Vj33+ 
cells and then prevented their rapid disappearance (Figure 
2). Other experiments, utilizing thymectomized mice, 
showed that the elevated levels of Vf33’ cells induced by 
SEA plus LPS were maintained for greater than 80 days 
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Figure 2. Kinetics of Appearance of Rescued V63+ T Cells 
Mice were injected with 0.02 ug SEA on day 0 and/or 50 ug LPS 24 
hr later. At day 2, 5, and 12 after SEA injection, spleen and LN T cells 
were isolated and analyzed as in Figure 1. Each point represents the 
mean percentage f SEM from 6 mice in two separate experiments. 
Only the data from the spleen cells are shown. Results from LN were 
similar. Day 0, normal; open square, LPS alone: closed diamond, SEA 
alone; open circle, SEAILPS. 
(unpublished data). Because the SEA-targeted cells in 
LPS-treated mice did not go on to die, LPS is not simply 
slowing the T cell response to SEA but rather dramatically 
changing the outcome of the response. 
i: 
0 103 104 16 106 104 10s 106 
Total T cells/well 
101 loz 103 104 105 104 16 106 
Vp3+ T cells/well VpS+ T cells/well 
Figure 3. T Cells Rescued from SEA-Induced Death Respond Less 
Well to SEA In Vitro 
T cells were purified from the LN of mice given SEA with or without 
LPS 1 day later. T cells were isolated 7 days after the SEA injection 
and titrated in triplicate into tissue culture wells containing mitomycin 
C-treated T cell-depleted spleen cells and SEA or SEB at 1 f.@ml or 
10 uglml, respectively. PHjthymidine was added 3 days later for 8 hr 
and the cultures were harvested. The data show the mean cpm f 
SEM from the triplicate samples. The data are from one of two similar 
experiments. In each experiment, T cells from two identically treated 
mice were assayed. Open square, normal; open diamond, SEA alone; 
open circle, LPS alone; open triangle, SEAILPS-treated mice. 
LPS-Rescued Cells Are Not as Active 
as Control Cells 
To find out whether T cells rescued from SEA-induced 
death by LPS could still respond to the superantigen, T 
cells from treated and control animals were tested for their 
ability to divide in response to SEA or, as a control, SEB 
The data (Figures 3c, 3d) show that cells from SEA and 
SEAILPS-treated mice responded to SEB as strongly as 
the cells from normal or LPS-treated animals did. When 
responses were plotted according to the total numbers of 
T cells/culture well, this was also true for responses to 
SEA (Figure 3a). However, T cells from animals given LPS 
as well as SEA included higher percentages of Vf33+ T 
cell8 than T cells from the other mice; therefore, when the 
results were plotted against the numbers of VpS+ T cells/ 
well (Figure 3b), it was clear that VpS+ T cells from mice 
given SEA and LPS responded to SEA with only about 
60% the activity of their counterparts from the other mice. 
It is also worth noticing that in this experiment, and previ- 
ous experiments reported by this laboratory, we observed 
no evidence for selective nonreactivity induced by treat- 
ment of mice with SEA alone (McCormack et al., 1994). 
Cytokine analyses demonstrated that SEA treatment with 
or without LPS had no measurable effect on the ability of 
T cells to make IL-2 in response to SEA. Also, none of the 
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Figure 4. CTLA4-Ig Does Not Block LPS-Mediated T Cell Rescue 
Individual mice were given SEA on day 0 Jo LPS 24 hr later. Some 
animals received CTlACIg or a control chimeric antibody, L6, at the 
times indicated in the Results. One mouse was used per group and 
the timing of treatments are given in the text. Spleen and LN cells were 
analyzed 9 days after SEA injection by flow cytometry to determine the 
percent of CD4 (shaded bars) or CD6 (stippled bars) Vf33’ T cells. 
The data represent mean percentages f SEM from three separate 
experiments. 
mice contained Tcells that could produce significant levels 
of IL-4 in response to SEA (data not shown). 
SEA stimulates T cells bearing Vj31, V83, and VP11 but 
only V83+ cells were analyzed in these experiments. 
Therefore, it is possible that the drop in proliferative re- 
sponse to SEA was affected by unappreciated falls in the 
percentages of T cells bearing Vgl and VP1 1. More likely, 
however, these results do indicate a small decrease in the 
activity of the Vf33+ cells themselves. 
Rescue by LPS Is Not Mediated Through 
B7 Costimulation 
We demonstrated, as others have before (Razi-Wolf et al., 
1992; Hathcock et al., 1993) that the dose of LPS given 
to the mice in these experiments rapidly induced the ap- 
pearance of 87 on B cells (data not shown). Therefore, it 
was possible that LPS rescue of SEA-targeted cells was 
caused by induction of the costimulatory molecules, 87-l 
Table 2. Blocking of CTLA4/B7 Interaction Inhibits the In Vivo 
Priming for Pigeon Cytochrome C (Emulsified in Complete Freund’s 
Adjuvant) 
Percentage of CD4+ V53+ Cells Expressing TCR 
Vall in Immunized BlO.BR Mice 
Experiments CFAfPCC CFA/PCC + CTLACIg CFA/PCC + L6 
Experiment 1 26.46 16.56 25.55 
Experiment 2 34.99 24.90 36.25 
Three-color flow cytometry, as described in Experimental Procedures 
was utilized to determine the percent of CD4+ V53+ T cells expressing 
TCR Vall from a pool of LN cells taken from two appropriately immu- 
nized mice. For levels of Vail expression in normal female BlO.BR/ 
SgSnJ mice see Figure 7b. 
and 87-2, on presenting cells. If so, rescue should be 
blocked by coadministration of the B7-binding molecule, 
CTLA4 (Linsley et al., 1992). To test this idea, mice were 
treated with SEA at 0 hr, LPS at 24 hr, and were given 200 
c1g of the human CTLA4 IgGl fusion protein (CTLAQIg) 
intravenously 12 hr before and at the time of LPS. A control 
group of mice received a human IgGl control antibody 
(L6). Analysis of CD4 and CD8 T cells expressing Vj33 in 
spleens and LN 9 days after SEA injection demonstrated, 
perhaps surprisingly, that CTLACIg inhibition of 87 inter- 
action with cell surface CD28 and CTLA4 had no effect 
on the rescue mediated by LPS (Figure 4). Less surpris- 
ingly, this inhibition had no effect on the killing effects of 
SEA given alone (Figure 4). 
To demonstrate that effective amounts of CTLA4-Ig had 
been given to the mice, the reagent was assayed for its 
ability to inhibit T cell priming to a conventional protein 
antigen in vivo. BlO.BR mice were primed with PCC 88- 
104 in complete Freund’s adjuvant (CFA) and at the time 
of priming and 12 hr after priming mice were given 200 
pg of CTLACIg or L6 intravenously. CTLACIg profoundly 
inhibited priming to PCC as measured by a reduction in 
the percent of draining LN T cells bearing the receptors 
(CD4+ V83+ Vu1 1’) characteristic of PCC reactive cells 
(Table 2; Fink et al., 1986; Sorger et al., 1987). Further- 
more, CTLA4-lg treatment also reduced by at least 50% 
the ability of T cells in the PCC-primed LNs to respond to 
PCC (Figure 5). 
These results suggest that the CTLACIg was at effective 
levels in vivo, and that LPS-induced rescue of SEA- 
targeted cells was not due to induction of costimulatory 
B7-like proteins on SEA-presenting cells. 
Proinflammatory Cytokines Are Involved 
in LPS Rescue 
One major outcome of exposure to LPS is the production 
of the three major proinflammatory cytokines, TNFa, IL-l, 
and IL-6 (Waage et al., 1989). Previous data have shown 
that TNFa can regulate the production of the other two 
cytokines (Fong et al., 1989). Thus, TNFa is a pivotal link 
in the initiation of an inflammatory response (Beutler and 
Cerami, 1989). We tested the idea that TNFa was linked 
to the rescue of V63+ T cells from death by giving mice 
SEA-, LPS-, and TNFa-neutralizing antibodies. As shown 
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Figure 5. CTLA4-lg Inhibits CFA/PCC Priming In Vivo 
Immunizations were carried out as described in the Results. T cells 
were purified by passage of LN cells over nylon wool columns. Stimula- 
tions were done as those in Figure 3 except that 3 x 105 T cells were 
serially P-fold diluted and 100 pg/ml of PCC was added as antigen. 
The data shown are from one experiment representative of two. LN 
cell populations were from mice given PCC alone (open square); PCC 
and CTLA4-lg (open diamond); PCC and L6 (open circle). 
in Figure 6, anti-TNFa significantly interfered with the abil- 
ity of LPS to rescue SEA-targeted T cells (p < 0.05). Anti- 
body to IFNy had a less dramatic effect. In control experi- 
ments, we tested a nonspecific rat IgG and anti-lL-4, both 
of which were less effective than anti-TNFa. 
With these results in mind, we tested the effects of anti- 
TNFa in a model that combines both SEA-mediated dele- 
tion and conventional antigen responses to PCC 88-104 
in CFA (McCormack et al., 1994). We show that anti-TNFa 
did not interfere with superantigen-mediated deletion (Fig- 
ure 7a) nor the ability of T cells to respond to the conven- 
tional peptide PCC (Figure 7b). 
LPS Protects Superantigen-Stimulated T Cells 
from Fas-Mediated Death 
The surface protein, Fas, has recently been shown to be 
involved in the death of mature T cells (Watanabe- 
Fukunaga et al., 1992; Singer and Abbas, 1994). To find 
out whether LPS was interfering with Fas-based death, 
VpS+ T cells from mice treated with SEA, LPS, or SEA 
and LPS were stained for Fas expression. The Vp3+ T 
cells in mice given SEA bore more Fas than unstimulated 
controls. This was also true for the V/33+ cells in mice given 
SEA and LPS. In fact, Vp3+ cells from these latter mice 
bore even more Fas that their counterparts in mice given 
SEA alone (data not shown). Thus, LPS did not prevent 
T cell death by inhibiting expression of surface Fas. 
To find out how the Fas-positive cells survive in mice 
given SEA, LPS, or both, cells from these animals and 
control mice were cultured alone or in the presence of 
immobilized anti-Fas. As shown in Figure 8, Vp3+ cells 
from mice given SEA died in large numbers in vitro, proba- 
bly because they were committed to die before they were 
removed from the animal. Vf33’cells from mice given SEA 
SEA n l n 
LPS n n n 
anti-TNFa cl cl n 
anti-IFNy cl Cl 
Figure 6. TNFa Is Involved in LPS Rescue 
Mice were injected with SEA and 24 hr later given LPS and anti-TNFa 
or anti-IFNy as described in Experimental Procedures. Spleen (stip 
pled bars) and LN cells (striped bars) were processed and stained as 
described in Figure 1. Each bar represents the pooled mean percent- 
age f SEM from groups of three mice in the same experiment. Two 
other similar experiments were conducted, which yielded comparable 
results. 
and LPS did not die in vitro, whether or not they were 
exposed to anti-Fas (Figures 8a and ad). 
The anti-Fas used in these experiments could kill sensi- 
tive Tcells. For example, a mouse Tcell line, L1210, which 
had been transfected with the gene for murine Fas, was 
killed by the anti-Fas (Figures 8b and 8e). Likewise, 
transgenic TCR Vp3 Vu1 1 Tcells that had been stimulated 
with SEA in vitro and were Fas positive (data not shown), 
were also killed by anti-Fas (Figures 8c and 8d). TNFa, 
however, did not block Fas-induced death when the 
transgenic TCR population was cultured in vitro with SEA 
and TNFa (data not shown). 
These results suggest that coadministration of LPS with 
superantigen blocks cell death by interfering with the Fas 
signaling pathway. 
Discussion 
As T cells develop in the thymus they are screened for 
their ability to react with peptide-MHC complexes present 
in that organ. Thymocytes that react with high affinity with 
these complexes die (Lo et al., 1986; Kappler et al., 1987; 
Kisielow et al., 1988). Thus, components of self that can 
reach the thymus filter out the developing cells that might 
react with them. 
Not all self-components reach the thymus; therefore, 
some potentially autoreactive T cells escape this filtering 
process and reach the periphery (Patterson, 1960; Burns 
et al., 1983; Acha-Orbea et al., 1988). It is clear that some 
LPS Blocks Staphylococcal Enterotoxin A-Mediated T Cell Death 
267 
01234560 2tl40 60 80 
7‘ vp3 Erpreraic." 9b "all Expression 
Figure 7. Anti-TNFa Does Not Inhibit PCC Priming or Block SEA- 
Mediated Deletion 
Groups of three mice were given SEA and PCC in CFA with or without 
anti-TNFa. The LN from each group were pooled 7 days later, T cells 
were isolated as described in Figure 1, and stained for CD4, V63. and 
Vail. The percent of CD4 cells expressing VP3 (a), and the percent 
of CD4 V63 cells expressing Vall (b) was determined by three-color 
flow cytometry. The data show the mean i SEM from three separate 
experiments. 
other process(es) must control the reactivities of these 
cells. It has been suggested that these processes involve 
confrontation of the autoreactive cells with self-antigen on 
nonstimulatory cells, such as resting 6 cells (Jenkins and 
Schwartz, 1987). It has been shown that these cells are 
nonstimulatory because they present antigen to T cells in 
the absence of other proteins that provide essential costi- 
mulation (Enyon and Parker, 1992; Fuchs and Matzinger, 
1992). The experiments described in this paper support 
previous experiments along these lines, since CTLA4-lg, 
which interferes with the ability of T cell surface proteins 
to react with ligands such as 67-l and 87-2 (Linsley et 
al., 1991, 1992), was shown to inhibit T cell priming by 
peptides in the presence of mycobacterial adjuvants. 
In this report, we demonstrate that exposure of T cells 
to superantigens causes T cell death, and LPS, given at 
the appropriate time, prevents this death. This result is 
reminiscent of those published many years ago (Chiller 
and Weigle, 1973; Parks et al., 1981), which showed that 
LPS can inhibit induction of tolerance by soluble proteins. 
Rescue in this case is not controlled by 87 expression, 
however, since interference with 87 does not affect res- 
cue. Surprisingly, rescue depends on inflammatory cyto- 
kines such as TNFa and, to a lesser extent, IFNy. This 
result is consistent with the fact that LPS can only rescue 
T cells if it is given at the same time, or shortly after, the 
superantigen. Production of TNFa and IFNy occurs almost 
immediately after LPS is given and does not continue for 
a long time thereafter. By contrast, the increase in 87 
levels induced by LPS persists for several days after the 
LPS is given. 
Superantigens stimulate the production of TNFa in vivo 
even in the absence of LPS (Miethke et al., 1992). If TNFa 
makes an essential contribution to LPS rescue of T cells, 
it is therefore surprising that TNFa cannot play a similar 
role when mice are challenged with superantigens alone. 
Perhaps LPS stimulates the production of more TNFa than 
SEA does (Miethke et al., 1992; Wollenberg et al., 1993) 
and high levels of the cytokine are required for rescue. 
Figure 6. V63 T Cells from SEA!LPS-Primed Mice Are Resistant to 
FAS-Induced Death 
A pair of mice was injected intraperitoneally with 0.04 pg of SEA at 
time 0 (closed diamond). Another pair received 30 ug LPS 24 hr later 
(open circle). Two other mice were injected with both the SEA and 
LPS (open triangle). Two control mice were untreated (open square). 
LN cells were harvested from the animals 2 days after the SEA injec- 
tion. Samples of these cells were used to measure the percentages 
of CD4+ cells bearing V63 in the preparations. The cells were then 
cultured at l@ cells/ml in plastic wells, which had (d) or had not (a) 
previously been coated with an anti-Fas monoclonal antibody. A mu- 
rine T cell tumor line, L1210, transfected with murine FAS was placed 
in culture at the same cell concentration in b and e (e was anti-Fas 
coated). In c and f (f was anti-Fas coated), LN cells from AD10 
transgenic mice (TCR V63 Val l), which had been previously activated 
with SEA(lOOng/ml)for24 hrinvitro, were usedattheaforementioned 
cell concentration. After 16 hr in culture at 37%, cells in a and b were 
stained for CD4 VP3 and the rest of the populations were stained with 
propidium iodide to determine DNA content. Apoptotic cells are cells 
that contain less DNA than GO type cells (2n) and in each, the percent 
of apoptotic cells is given (see analysis bar in b, c, e, and f). These 
are data from one experiment, comparable with three others. 
Alternatively, perhaps other components of the response 
to LPS are required for T cell rescue and, although TNFa 
is necessary for rescue, it may not be sufficient. 
Other procedures have been reported that interfere with 
superantigen-induced tolerance. For example, it has been 
shown that Nippostrongylus brasiliensis can rescue Tcells 
from superantigen-mediated anergy, and that the rescued 
cells are converted from a Thl to a Th2 phenotype (Rocken 
et al., 1992, 1994). However, there is no evidence that 
cells rescued by LPS in our experiments are converted 
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from Thl to Th2 ceils, since the rescued cells secrete 
normal amounts of IL-2 and IFNy and do not produce IL-4 
when challenged in vitro (data not shown). Likewise, the 
glucocorticoid receptor antagonist, RU-38488 (mifepri- 
stone), and pertussis toxin can inhibit SEB-mediated T 
cell death (Gonzalo et al., 1993, 1994). However, in those 
studies it is unknown whether TNFa is involved in the 
rescue. 
We do not know whether LPS, TNFa, or both rescues 
T cells by acting directly on the T cell or indirectly, via 
effects on B cells or macrophages. Whether the effect 
is direct or indirect, the outcome is clear, however. The 
SEA-challenged cells survive after exposure to LPS be- 
cause LPS, TNFa, or both somehow interferes with the 
ability of Fas, on the surface of the challenged cells, to 
induce death. Since the receptors for TNFa and Fas are 
members of the same protein family (reviewed by Beutler 
and van Huffel, 1994), this may be due to cross talk be- 
tween the signal transduction pathways induced by the 
two receptors. Whatever the mechanism, the finding that 
TNFa affects T cell death is of some interest, since this 
cytokine has been shown to inhibit (Jacob and McDevitt, 
1988; Satoh et al., 1989; Jacob et al., 1990) or stimulate 
(Yang et al., 1994) the development of autoimmunity in 
experimental animals. Moreover, studies in transgenic 
mice have shown that localized expression of TNFa can 
lead to insulitis and, under some circumstances, overt dia- 
betes (Higuchi et al., 1992; Guerder et al., 1994). Also 
Drake et al. (1994) have shown that susceptibility to auto- 
immune disease in NZB x NZW animals is closely linked 
to one of the genes coding for the TNF receptor. All these 
data suggest that TNFa can affect T cell tolerance, per- 
haps by interfering with FAS-based death of mature T cells 
as indicated in this paper. 
Overall, the data in this report demonstrate two ways 
in which microbial products can affect peripheral T cells. 
Exposure to LPS at a suitable time after exposure to an 
otherwise deleting superantigen prevents T cell death, an 
effect that is mediated by the inflammatory cytokines 
TNFa and IFNy and interference with the Fas-mediated 
death pathway. Mycobacteria in CFA stimulate T cell prim- 
ing, but, in this case, the stimulation is mediated bycostim- 
ulatory molecules such as 87. Thus, bacterial products 
and inflammation can interfere with T cell tolerance in sev- 
eral ways, effects that may contribute to the long-suspected 
effects of inflammatory infections on autoimmunity. 
Experimental Procedures 
Mice 
Female BlO.BR/SgSnJ (H-29 mice were purchased from the Jackson 
Laboratory (Bar Harbor, Maine) and maintained in our animal facility 
under specific pathogen-free conditions. in all experiments, mice be- 
tween the age of 6-16 weeks were used. 
Reagents, ExPerimental Protocols, and Antibodies 
LPS was purchased from Sigma Corporation (St. Louis, Missouri). 
Mice were injected with 50 ag LPS intravenously. Animals treated with 
SEA received 0.02 ug of the material (Sigma) intraperitoneally, except 
in the experiment shown in Figure 1, in which 0.04 pg was used. 
The dose was changed for this experiment because of batch to batch 
variation in the activity of the SEA. 
Mice were primed with PCC 66-104 (Macromolecular Resources, 
Colorado State University, Fort Collins, Colorado) with asubcutaneous 
injection in the base of the tail of a 1:l mixture of 100 ug of PCC in 
CFA in a 50 cl volume. 
In experiments designed to block CD26-B7-1 and CD26-87-2 inter- 
actions, CTLA4lg (Linsieyet al., 1991) and an isotype-matched control 
chimeric antibody, L6, were injected at 200 ng intraperitoneally or 
intravenously as indicated in the text. 
TNFa and IFNy were neutralized in vivo using the monoclonal anti- 
bodies MPG-XT22 and XMG1.2, respectively (Abrams et al., 1992; 
Chetwinski et al., 1987; gift of Dr. A. Zlotnik, DNAX Research Institute, 
Palo Alto, California). Hybridomasupernatants were purified over pro- 
tein G (Pharmicia LKB Biotechnology, Piscastaway, New Jersey) and 
tested for the presence of LPS using the Limulus assay kit from Sigma. 
Both purified antibodies contained less than 4.0 EUlml LPS. Mice were 
injected with 200 pl 1.5 mg of the neutralizing antibodies intraperftone- 
ally in sterile balanced salt solution (BSS) immediately after SEA injec- 
tion. A second injection of 1.5 mg was administered intravenously 12 
hr after the LPS injection. 
The antibodies used for staining were as follows: anti-TCRV53, 
KJ25-607.7 (Puilen et al., 1966); anti-TCRVj3S, F23.1 (Staerz et al., 
1965); anti-TCRV514, 142 (Liao et al., 1989). These antibodies were 
biotinylated. Anti-CD4 and anti-CD6 (GK1.5, Dialynas et al.. 1963 and 
53.6.72, Ledbetter and Herzenberg, 1979, respectively) were fluoro- 
stein isothiocyanate conjugated. Anti-TCRVall and anti-murine 87, 
both fluorescein isothiocyanate conjugated, streptavidin-CyChrome, 
streptavidin-phycoerythrin and anti-murine FAS were all purchased 
from PharMingen, Palo Alto, California. 
L1210 ceils transfected with murine Fas and AD10 TCR transgenic 
mice, were gifts from Drs. R. Duke (University of Colorado Health 
Sciences Center, Denver, Colorado) and S. Hedrick (University of Cali- 
fornia at San Diego, San Diego, California), respectively. 
Cell Processing and Staining 
Spleens were removed, teased through nylon mesh (Falcon, Becton 
Dickinson, Franklin Lakes, New Jersey), and then subjected to ammo- 
nium chloride to lyse red blood cells. Inguinal, brachial, and axillary 
LN were teased into single-cell suspensions and washed with BSS. 
T cells from spleen or LN populations were purified on nylon wool 
columns as described previously (Julius et al., 1973). In brief, 10 cc 
syringes were filled with 0.6 g of washed and brushed nylon wool. The 
columns were prepared with warm BSS 5% fetal bovine serum (FBS), 
after which the cells were loaded in a 2 ml volume and incubated for 
30 min at 37°C. After draining 2 ml away, the columns were incubated 
for an additional 30 min followed by elution with IO ml of warm BSS 
5% FBS. 
Two- and three-color staining was performed as described pre- 
viously (Callahan et al., 1990). Incubation of the primary antibody with 
the cells was done in the presence of anti-Fc 24.G2 (Unkeless, 1979) 
human y globulin, and normal mouse serum to block nonspecific bind- 
ing of the staining antibody. After incubation for 25 min at 37OC, the 
cells were washed three times with staining buffer (phosphate-buffered 
saline, 0.1% sodium azide, and 2% FBS). Streptavidin-phycoerythrin, 
or streptavidin-CyChrome in the case of three color staining, was 
added at a 1:lO dilution and the suspension was incubated on ice for 
2.5 min in the dark. After several washes with staining buffer, the sam- 
ples were analyzed on a FACScan (Becton-Dickinson, Immunocytome- 
try Systems, San Jose, California). Gates were set onlyon viable cells 
and usually >lO’ cells were analyzed using PC Lysis (Becton Dick- 
inson). 
To determine DNA content, propidium iodide at 5 vg/ml (Sigma), 
0.3% saponin (Sigma), 50 uglml RNAase (Boehringer Mannheim, Indi- 
anapolis, Indiana), 5 mM EDTA in phosphate-buffered saline, was used 
to resuspend cells. After a 20 min incubation at room temperature in 
the dark, the cells were analyzed on a FACScan. 
Stimulation Assay 
Peripheral LN cells were isolated from primed mice and nylon- 
adherent cells were removed by nylon wool separation under sterile 
conditions as described above. The enriched T cell populations were 
cultured in DMEM supplemented with 10% FBS, sodium bicarbonate, 
antibiotics, P-mercaptoethanol, sodium pyruvate. and nonessential 
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amino acids (CTM). The T cells were titrated in triplicate into the wells 
of 96-well flat-bottomed plates (Falcon, Becton Dickinson) containing 
5 x 105 T cell-depleted mitomycin C-treated splenocytes/well. Anti- 
gen concentrations were 100 t@ml of intact PCC protein, 10 ug/ml 
SEB, or 1 uglml SEA. After culture for 72 hr at 37OC, 10% COz, 1 pCi 
of [‘Hlthymidine (Amersham Life Sciences, Arlington Heights, Illinois) 
in sterile BSS at a 10 ul volume was added to each well and the plates 
were incubated for an additional 6 hr. At the end of the incubation, 
cells were harvested onto glass fiber filters using a PHD cell harvester 
(Cambridge Technology, Watertown, Massachusetts). The incorpora- 
tion of PHjthymidine was determined by scintillation counting using 
a Beckman LS306 scintillation counter. 
Statlstlcal Analyses 
A student’s t test was used to calculate statistical differences between 
groups within an experiment and a P value less than 0.05 is considered 
significant, JMP software was used for this purpose (SAS Institute, 
Incorporated, Cary, North Carolina). Statistical differences between 
the slopes of proliferation curves were calculated by a program devel- 
oped by one of us (J. W. K). 
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